Get the Stockscreener App
2.19
0.45%
-0.01
After Hours:
2.21
0.02
+0.91%
Oramed Pharmaceuticals Inc stock is traded at $2.19, with a volume of 86,258.
It is down -0.45% in the last 24 hours and down -11.69% over the past month.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
See More
Previous Close:
$2.20
Open:
$2.18
24h Volume:
86,258
Relative Volume:
0.77
Market Cap:
$89.80M
Revenue:
$2.70M
Net Income/Loss:
$5.53M
P/E Ratio:
19.91
EPS:
0.11
Net Cash Flow:
$-10.55M
1W Performance:
-8.37%
1M Performance:
-11.69%
6M Performance:
-1.35%
1Y Performance:
-7.98%
1-Day Range:
$2.09
$2.22
1-Week Range:
$2.09
$2.40
52-Week Range:
$1.82
$3.09
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
Name
Oramed Pharmaceuticals Inc
Sector
Industry
Phone
646-844-1164
Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Compare ORMP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ORMP
Oramed Pharmaceuticals Inc
|
2.19 | 87.67M | 2.70M | 5.53M | -10.55M | 0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-12-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-18-22 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-20-21 | Initiated | Canaccord Genuity | Buy |
| Feb-09-21 | Initiated | National Securities | Buy |
| Dec-03-20 | Initiated | Alliance Global Partners | Buy |
| Mar-11-20 | Initiated | Aegis Capital | Buy |
| Sep-11-19 | Initiated | Ladenburg Thalmann | Buy |
| Dec-11-17 | Resumed | B. Riley FBR, Inc. | Buy |
| May-26-16 | Reiterated | FBR Capital | Outperform |
| Dec-01-15 | Reiterated | H.C. Wainwright | Buy |
| Nov-19-15 | Initiated | FBR Capital | Outperform |
| Apr-13-15 | Resumed | MLV & Co | Buy |
| Jan-30-14 | Reiterated | Aegis Capital | Buy |
| Jan-08-14 | Reiterated | Aegis Capital | Buy |
| Jan-08-14 | Initiated | MLV & Co | Buy |
| Dec-03-13 | Initiated | Aegis Capital | Buy |
View All
Oramed Pharmaceuticals Inc Stock (ORMP) Latest News
Forecasting Oramed Pharmaceuticals Inc. price range with options dataJuly 2025 Opening Moves & Reliable Price Action Trade Plans - newser.com
How Oramed Pharmaceuticals Inc. (OJU1) stock correlates with oil marketsTrade Ideas & Low Risk Investment Opportunities - newser.com
Is Oramed Pharmaceuticals Inc. stock a top pick in earnings seasonGlobal Markets & Entry Point Confirmation Signals - newser.com
Leading vs lagging indicators on Oramed Pharmaceuticals Inc. performance2025 Key Lessons & AI Based Buy/Sell Signal Reports - newser.com
Custom watchlist performance reports with Oramed Pharmaceuticals Inc.Portfolio Growth Summary & Real-Time Sentiment Analysis - newser.com
When is the best time to exit Oramed Pharmaceuticals Inc.Market Volume Summary & Low Risk Entry Point Guides - newser.com
Will Oramed Pharmaceuticals Inc. (OJU1) stock maintain strong growthJuly 2025 Recap & Weekly Market Pulse Alerts - newser.com
Will Oramed Pharmaceuticals Inc. benefit from macro trends2025 Top Decliners & Daily Profit Focused Stock Screening - newser.com
Why Oramed Pharmaceuticals Inc. stock remains undervaluedWeekly Trade Recap & Daily Profit Maximizing Trade Tips - newser.com
What sentiment indicators say about Oramed Pharmaceuticals Inc. stock2025 Stock Rankings & Safe Entry Trade Reports - newser.com
Ranking Oramed Pharmaceuticals Inc. among high performing stocks via toolsCEO Change & Short-Term Trading Opportunity Alerts - newser.com
Is Oramed Pharmaceuticals Inc. (OJU1) stock resilient in recession scenariosPortfolio Value Report & Low Risk High Win Rate Stock Picks - newser.com
Published on: 2025-11-06 04:05:28 - newser.com
What does recent volatility data suggest for Oramed Pharmaceuticals Inc.Portfolio Return Report & Fast Momentum Stock Entry Tips - newser.com
Why Oramed Pharmaceuticals Inc. stock is a must watch in 20252025 Market Sentiment & Daily Profit Focused Screening - newser.com
Pattern recognition hints at Oramed Pharmaceuticals Inc. upsideMarket Performance Summary & Fast Exit and Entry Trade Guides - newser.com
Will Oramed Pharmaceuticals Inc. stock continue upward momentumJuly 2025 News Drivers & Intraday High Probability Setup Alerts - newser.com
What risks investors should watch in Oramed Pharmaceuticals Inc. stockWeekly Volume Report & Daily Profit Maximizing Tips - fcp.pa.gov.br
Using Ichimoku Cloud for Oramed Pharmaceuticals Inc. technicalsQuarterly Earnings Report & Technical Confirmation Trade Alerts - newser.com
Applying sector rotation models to Oramed Pharmaceuticals Inc.2025 Growth vs Value & Daily Momentum Trading Reports - newser.com
Tools to assess Oramed Pharmaceuticals Inc.’s risk profile2025 Institutional Moves & Growth Focused Stock Pick Reports - newser.com
What insider trading reveals about Oramed Pharmaceuticals Inc. stockWeekly Profit Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Can technical indicators confirm Oramed Pharmaceuticals Inc.’s reversal2025 Geopolitical Influence & Consistent Profit Trading Strategies - newser.com
How Oramed Pharmaceuticals Inc. stock reacts to global recession fearsAnalyst Downgrade & Consistent Return Strategy Ideas - newser.com
Is Oramed Pharmaceuticals Inc. stock a defensive play in 2025July 2025 Review & Risk Controlled Swing Trade Alerts - newser.com
Published on: 2025-11-05 01:37:57 - newser.com
Published on: 2025-11-05 00:37:38 - newser.com
Visualizing Oramed Pharmaceuticals Inc. stock with heatmapsWeekly Trend Summary & Technical Entry and Exit Tips - newser.com
Will breakout in Oramed Pharmaceuticals Inc. lead to full recoveryMarket Growth Review & Free Community Consensus Stock Picks - newser.com
Oramed Pharmaceuticals Inc Stock (ORMP) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.44%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):